Page last updated: 2024-08-25

honokiol and Pancreatic Neoplasms

honokiol has been researched along with Pancreatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad, A; Arora, S; Averett, C; Bhardwaj, A; Carter, JE; Khan, MA; Khushman, M; Singh, AP; Singh, S; Srivastava, SK1
Arora, S; Bhardwaj, A; McClellan, S; Singh, AP; Singh, S; Srivastava, SK; Wang, B1

Other Studies

2 other study(ies) available for honokiol and Pancreatic Neoplasms

ArticleYear
Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
    Carcinogenesis, 2016, 11-01, Volume: 37, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Communication; Cell Line, Tumor; Down-Regulation; Female; Gene Expression; Hedgehog Proteins; Humans; Lignans; Liver Neoplasms, Experimental; Lung Neoplasms; Mice; Pancreatic Neoplasms; Receptors, CXCR4; Tumor Microenvironment; Xenograft Model Antitumor Assays

2016
Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells.
    PloS one, 2011, Volume: 6, Issue:6

    Topics: Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Biphenyl Compounds; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Deoxycytidine; Drug Screening Assays, Antitumor; Drug Synergism; G1 Phase; Gemcitabine; Humans; Lignans; NF-kappa B; Pancreatic Neoplasms; Protein Transport

2011